NTRK2 and laryngeal carcinoma: Even though the underlying mechanism remains unclear, TrkB was frequently overexpressed in highly metastatic laryngeal cancer cell lines, and in clinical laryngeal cancer samples, acting as a key regulator of the c-Src-mediated activation of PI3K/AKT signal pathway and driving EMT [67].